These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6936083)

  • 21. [Treating acne: avoid the development of antibiotic resistance by applying topical and combined therapy].
    Abeck D
    MMW Fortschr Med; 2003 Dec; 145(51-52):29. PubMed ID: 14974325
    [No Abstract]   [Full Text] [Related]  

  • 22. Trends in nalidixic acid resistance in nontyphoidal Salmonella isolated from 1999 to 2002: decreased susceptibility to 6 fluoroquinolones.
    Rodriguez-Avial I; Rodriguez-Avial C; López O; Picazo JJ
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):261-4. PubMed ID: 15893900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nalidixic acid resistance in Salmonella strains with decreased susceptibility to ciprofloxacin isolated from humans in Turkey.
    Ercis S; Erdem B; Hasçelik G; Gür D
    Jpn J Infect Dis; 2006 Apr; 59(2):117-9. PubMed ID: 16632912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibiotic prophylaxis in corneal storage media.
    Nirankari VS; Dandona L; Rodrigues MM; Schwalbe RS
    Trans Am Ophthalmol Soc; 1994; 92():181-96; discussion 196-201. PubMed ID: 7886863
    [No Abstract]   [Full Text] [Related]  

  • 25. Biofilm formation by Propionibacterium acnes is associated with increased resistance to antimicrobial agents and increased production of putative virulence factors.
    Coenye T; Peeters E; Nelis HJ
    Res Microbiol; 2007 May; 158(4):386-92. PubMed ID: 17399956
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro activity of nadifloxacin against several Gram-positive bacteria and analysis of the possible evolution of resistance after 2 years of use in Germany.
    Alba V; Urban E; Angeles Dominguez M; Nagy E; Nord CE; Palacín C; Vila J
    Int J Antimicrob Agents; 2009 Mar; 33(3):272-5. PubMed ID: 19095414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antibiotic susceptibility of black-pigmented Bacteroides isolated from the human oral cavity].
    Saito T; Setsu E; Kawanabe J; Hirasawa M
    Nichidai Koko Kagaku; 1986 Sep; 12(3):357-62. PubMed ID: 3467196
    [No Abstract]   [Full Text] [Related]  

  • 28. [General antibiotic therapy in acne].
    Dréno B
    Rev Prat; 2002 Apr; 52(8):841-3. PubMed ID: 12053791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of zinc gluconate on propionibacterium acnes resistance to erythromycin in patients with inflammatory acne: in vitro and in vivo study.
    Dreno B; Foulc P; Reynaud A; Moyse D; Habert H; Richet H
    Eur J Dermatol; 2005; 15(3):152-5. PubMed ID: 15908296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibacterial activity of ent-kaurene diterpenoids from Rabdosia rosthornii.
    Kubo I; Xu Y; Shimizu K
    Phytother Res; 2004 Feb; 18(2):180-3. PubMed ID: 15022175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibiotic sensitivity of Corynebacterium acnes (Propionibacterium acnes).
    POCHI PE; STRAUSS JS
    J Invest Dermatol; 1961 Jun; 36():423-9. PubMed ID: 13736431
    [No Abstract]   [Full Text] [Related]  

  • 32. In vitro activity of kaempferol isolated from the Impatiens balsamina alone and in combination with erythromycin or clindamycin against Propionibacterium acnes.
    Lim YH; Kim IH; Seo JJ
    J Microbiol; 2007 Oct; 45(5):473-7. PubMed ID: 17978809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Propionibacterium acnes infection in patients with CSF shunts].
    Bordes A; Elcuaz R; Noguera FJ; Otemin C; Egas G
    Enferm Infecc Microbiol Clin; 1997 Jan; 15(1):24-7. PubMed ID: 9147504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative efficacy of clindamycin and benzoyl peroxide for in vivo suppression of Propionibacterium acnes.
    Gans EH; Kligman AM
    J Dermatolog Treat; 2002 Sep; 13(3):107-10. PubMed ID: 12227872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cationic hypericin derivatives as novel agents with photobactericidal activity: synthesis and photodynamic inactivation of Propionibacterium acnes.
    Hager B; Strauss WS; Falk H
    Photochem Photobiol; 2009; 85(5):1201-6. PubMed ID: 19659921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biofilm formation of the pathogens of fatal bacterial granuloma after trauma: potential mechanism underlying the failure of traditional antibiotic treatments.
    Qi X; Gao J; Sun D; Liang W; Wan Y; Li C; Xu X; Gao T
    Scand J Infect Dis; 2008; 40(3):221-8. PubMed ID: 17852906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluoroquinolone-resistant bacteria and methicillin-resistant Staphylococci from normal preoperative conjunctiva.
    Hori Y; Maeda N; Sakamoto M; Inoue T; Tano Y
    J Cataract Refract Surg; 2008 Apr; 34(4):711-2. PubMed ID: 18362000
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of free fatty acids on Propionibacterium acnes and Staphylococcus epidermidis].
    Nakagawa M; Nishijima S; Asada Y
    Nihon Hifuka Gakkai Zasshi; 1986 Sep; 96(10):1007-11. PubMed ID: 3795558
    [No Abstract]   [Full Text] [Related]  

  • 39. Identification and antibiotic sensitivity of bacteria isolated from periapical lesions.
    Vigil GV; Wayman BE; Dazey SE; Fowler CB; Bradley DV
    J Endod; 1997 Feb; 23(2):110-4. PubMed ID: 9220741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo selection during ofloxacin therapy of Escherichia coli with combined topoisomerase mutations that confer high resistance to ofloxacin but susceptibility to nalidixic acid.
    Cattoir V; Lesprit P; Lascols C; Denamur E; Legrand P; Soussy CJ; Cambau E
    J Antimicrob Chemother; 2006 Nov; 58(5):1054-7. PubMed ID: 16984897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.